nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRFAM7A—corpus luteum—testicular cancer	0.0827	0.248	CbGeAlD
Galantamine—CHRNA7—corpus luteum—testicular cancer	0.0668	0.2	CbGeAlD
Galantamine—BCHE—Cisplatin—testicular cancer	0.0376	0.465	CbGbCtD
Galantamine—CHRNA9—embryo—testicular cancer	0.0351	0.105	CbGeAlD
Galantamine—CHRNE—testis—testicular cancer	0.0179	0.0537	CbGeAlD
Galantamine—CHRNG—seminal vesicle—testicular cancer	0.0172	0.0515	CbGeAlD
Galantamine—CHRNA5—testis—testicular cancer	0.0125	0.0375	CbGeAlD
Galantamine—CYP3A4—Ifosfamide—testicular cancer	0.0118	0.145	CbGbCtD
Galantamine—CYP2D6—Vinblastine—testicular cancer	0.00981	0.121	CbGbCtD
Galantamine—CHRNA5—lymph node—testicular cancer	0.00908	0.0272	CbGeAlD
Galantamine—CHRNB4—testis—testicular cancer	0.00862	0.0258	CbGeAlD
Galantamine—CHRNA10—testis—testicular cancer	0.00759	0.0227	CbGeAlD
Galantamine—CYP3A4—Vinblastine—testicular cancer	0.00624	0.0771	CbGbCtD
Galantamine—CHRNB2—female gonad—testicular cancer	0.00615	0.0184	CbGeAlD
Galantamine—CYP2D6—Doxorubicin—testicular cancer	0.00603	0.0745	CbGbCtD
Galantamine—CYP3A4—Etoposide—testicular cancer	0.00562	0.0695	CbGbCtD
Galantamine—CHRNA10—lymph node—testicular cancer	0.0055	0.0165	CbGeAlD
Galantamine—CHRNB2—testis—testicular cancer	0.00545	0.0163	CbGeAlD
Galantamine—CHRNA3—testis—testicular cancer	0.00529	0.0158	CbGeAlD
Galantamine—CHRNB1—female gonad—testicular cancer	0.00516	0.0155	CbGeAlD
Galantamine—CHRFAM7A—female gonad—testicular cancer	0.00482	0.0144	CbGeAlD
Galantamine—CHRNB1—testis—testicular cancer	0.00457	0.0137	CbGeAlD
Galantamine—CHRFAM7A—testis—testicular cancer	0.00428	0.0128	CbGeAlD
Galantamine—ACHE—testis—testicular cancer	0.00397	0.0119	CbGeAlD
Galantamine—CHRNB2—lymph node—testicular cancer	0.00395	0.0118	CbGeAlD
Galantamine—CHRNA7—female gonad—testicular cancer	0.00389	0.0117	CbGeAlD
Galantamine—CYP3A4—Doxorubicin—testicular cancer	0.00383	0.0474	CbGbCtD
Galantamine—CHRNA3—lymph node—testicular cancer	0.00383	0.0115	CbGeAlD
Galantamine—BCHE—seminal vesicle—testicular cancer	0.00374	0.0112	CbGeAlD
Galantamine—CHRNA7—testis—testicular cancer	0.00345	0.0103	CbGeAlD
Galantamine—CHRNB1—lymph node—testicular cancer	0.00332	0.00993	CbGeAlD
Galantamine—ACHE—lymph node—testicular cancer	0.00288	0.00861	CbGeAlD
Galantamine—BCHE—testis—testicular cancer	0.00195	0.00584	CbGeAlD
Galantamine—CYP2D6—female gonad—testicular cancer	0.00146	0.00436	CbGeAlD
Galantamine—BCHE—lymph node—testicular cancer	0.00141	0.00423	CbGeAlD
Galantamine—CYP2D6—testis—testicular cancer	0.00129	0.00387	CbGeAlD
Galantamine—Body temperature increased—Cisplatin—testicular cancer	0.000601	0.00103	CcSEcCtD
Galantamine—Fatigue—Etoposide—testicular cancer	0.0006	0.00103	CcSEcCtD
Galantamine—Neuropathy peripheral—Epirubicin—testicular cancer	0.0006	0.00103	CcSEcCtD
Galantamine—Constipation—Etoposide—testicular cancer	0.000596	0.00102	CcSEcCtD
Galantamine—Urinary tract infection—Epirubicin—testicular cancer	0.000595	0.00102	CcSEcCtD
Galantamine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00059	0.00101	CcSEcCtD
Galantamine—Haemoglobin—Methotrexate—testicular cancer	0.00059	0.00101	CcSEcCtD
Galantamine—Hepatitis—Methotrexate—testicular cancer	0.000587	0.001	CcSEcCtD
Galantamine—Haemorrhage—Methotrexate—testicular cancer	0.000587	0.001	CcSEcCtD
Galantamine—Pollakiuria—Doxorubicin—testicular cancer	0.000587	0.001	CcSEcCtD
Galantamine—Haematuria—Epirubicin—testicular cancer	0.000584	0.000997	CcSEcCtD
Galantamine—Dizziness—Ifosfamide—testicular cancer	0.000583	0.000996	CcSEcCtD
Galantamine—Urinary tract disorder—Methotrexate—testicular cancer	0.00058	0.000991	CcSEcCtD
Galantamine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000579	0.000989	CcSEcCtD
Galantamine—Epistaxis—Epirubicin—testicular cancer	0.000577	0.000986	CcSEcCtD
Galantamine—Urethral disorder—Methotrexate—testicular cancer	0.000576	0.000983	CcSEcCtD
Galantamine—Weight decreased—Doxorubicin—testicular cancer	0.000575	0.000982	CcSEcCtD
Galantamine—Feeling abnormal—Etoposide—testicular cancer	0.000574	0.000981	CcSEcCtD
Galantamine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000573	0.000979	CcSEcCtD
Galantamine—Nausea—Dactinomycin—testicular cancer	0.000572	0.000977	CcSEcCtD
Galantamine—Pneumonia—Doxorubicin—testicular cancer	0.00057	0.000973	CcSEcCtD
Galantamine—Gastrointestinal pain—Etoposide—testicular cancer	0.000569	0.000973	CcSEcCtD
Galantamine—Visual impairment—Methotrexate—testicular cancer	0.000566	0.000967	CcSEcCtD
Galantamine—Vomiting—Ifosfamide—testicular cancer	0.000561	0.000958	CcSEcCtD
Galantamine—Hypersensitivity—Cisplatin—testicular cancer	0.00056	0.000957	CcSEcCtD
Galantamine—Bradycardia—Epirubicin—testicular cancer	0.000559	0.000956	CcSEcCtD
Galantamine—Renal failure—Doxorubicin—testicular cancer	0.000557	0.000951	CcSEcCtD
Galantamine—Rash—Ifosfamide—testicular cancer	0.000556	0.00095	CcSEcCtD
Galantamine—Dermatitis—Ifosfamide—testicular cancer	0.000555	0.000949	CcSEcCtD
Galantamine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000555	0.000949	CcSEcCtD
Galantamine—Haemoglobin—Epirubicin—testicular cancer	0.000552	0.000944	CcSEcCtD
Galantamine—Rhinitis—Epirubicin—testicular cancer	0.000551	0.000941	CcSEcCtD
Galantamine—Abdominal pain—Etoposide—testicular cancer	0.000551	0.000941	CcSEcCtD
Galantamine—Body temperature increased—Etoposide—testicular cancer	0.000551	0.000941	CcSEcCtD
Galantamine—Urinary tract infection—Doxorubicin—testicular cancer	0.00055	0.000941	CcSEcCtD
Galantamine—Haemorrhage—Epirubicin—testicular cancer	0.000549	0.000939	CcSEcCtD
Galantamine—Hepatitis—Epirubicin—testicular cancer	0.000549	0.000939	CcSEcCtD
Galantamine—Eye disorder—Methotrexate—testicular cancer	0.000549	0.000938	CcSEcCtD
Galantamine—Tinnitus—Methotrexate—testicular cancer	0.000547	0.000935	CcSEcCtD
Galantamine—Asthenia—Cisplatin—testicular cancer	0.000545	0.000932	CcSEcCtD
Galantamine—Cardiac disorder—Methotrexate—testicular cancer	0.000545	0.000931	CcSEcCtD
Galantamine—Urinary tract disorder—Epirubicin—testicular cancer	0.000543	0.000927	CcSEcCtD
Galantamine—Oedema peripheral—Epirubicin—testicular cancer	0.000541	0.000925	CcSEcCtD
Galantamine—Haematuria—Doxorubicin—testicular cancer	0.00054	0.000923	CcSEcCtD
Galantamine—Connective tissue disorder—Epirubicin—testicular cancer	0.00054	0.000923	CcSEcCtD
Galantamine—Urethral disorder—Epirubicin—testicular cancer	0.000539	0.00092	CcSEcCtD
Galantamine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000536	0.000915	CcSEcCtD
Galantamine—Epistaxis—Doxorubicin—testicular cancer	0.000534	0.000913	CcSEcCtD
Galantamine—Angiopathy—Methotrexate—testicular cancer	0.000533	0.00091	CcSEcCtD
Galantamine—Immune system disorder—Methotrexate—testicular cancer	0.00053	0.000906	CcSEcCtD
Galantamine—Visual impairment—Epirubicin—testicular cancer	0.000529	0.000905	CcSEcCtD
Galantamine—Nausea—Ifosfamide—testicular cancer	0.000524	0.000895	CcSEcCtD
Galantamine—Diarrhoea—Cisplatin—testicular cancer	0.00052	0.000889	CcSEcCtD
Galantamine—Bradycardia—Doxorubicin—testicular cancer	0.000518	0.000884	CcSEcCtD
Galantamine—Mental disorder—Methotrexate—testicular cancer	0.000514	0.000879	CcSEcCtD
Galantamine—Eye disorder—Epirubicin—testicular cancer	0.000513	0.000877	CcSEcCtD
Galantamine—Hypersensitivity—Etoposide—testicular cancer	0.000513	0.000877	CcSEcCtD
Galantamine—Tinnitus—Epirubicin—testicular cancer	0.000512	0.000875	CcSEcCtD
Galantamine—Malnutrition—Methotrexate—testicular cancer	0.000511	0.000873	CcSEcCtD
Galantamine—Haemoglobin—Doxorubicin—testicular cancer	0.000511	0.000873	CcSEcCtD
Galantamine—Flushing—Epirubicin—testicular cancer	0.00051	0.000871	CcSEcCtD
Galantamine—Cardiac disorder—Epirubicin—testicular cancer	0.00051	0.000871	CcSEcCtD
Galantamine—Rhinitis—Doxorubicin—testicular cancer	0.00051	0.000871	CcSEcCtD
Galantamine—Haemorrhage—Doxorubicin—testicular cancer	0.000508	0.000869	CcSEcCtD
Galantamine—Hepatitis—Doxorubicin—testicular cancer	0.000508	0.000869	CcSEcCtD
Galantamine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000502	0.000858	CcSEcCtD
Galantamine—Oedema peripheral—Doxorubicin—testicular cancer	0.000501	0.000856	CcSEcCtD
Galantamine—Dysgeusia—Methotrexate—testicular cancer	0.000501	0.000855	CcSEcCtD
Galantamine—Asthenia—Etoposide—testicular cancer	0.0005	0.000854	CcSEcCtD
Galantamine—Connective tissue disorder—Doxorubicin—testicular cancer	0.0005	0.000854	CcSEcCtD
Galantamine—Angiopathy—Epirubicin—testicular cancer	0.000499	0.000852	CcSEcCtD
Galantamine—Urethral disorder—Doxorubicin—testicular cancer	0.000498	0.000852	CcSEcCtD
Galantamine—Immune system disorder—Epirubicin—testicular cancer	0.000496	0.000848	CcSEcCtD
Galantamine—Back pain—Methotrexate—testicular cancer	0.000494	0.000845	CcSEcCtD
Galantamine—Arrhythmia—Epirubicin—testicular cancer	0.000491	0.000839	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—testicular cancer	0.00049	0.000837	CcSEcCtD
Galantamine—Vomiting—Cisplatin—testicular cancer	0.000483	0.000826	CcSEcCtD
Galantamine—Vision blurred—Methotrexate—testicular cancer	0.000482	0.000823	CcSEcCtD
Galantamine—Mental disorder—Epirubicin—testicular cancer	0.000481	0.000822	CcSEcCtD
Galantamine—Rash—Cisplatin—testicular cancer	0.000479	0.000819	CcSEcCtD
Galantamine—Dermatitis—Cisplatin—testicular cancer	0.000479	0.000818	CcSEcCtD
Galantamine—Malnutrition—Epirubicin—testicular cancer	0.000478	0.000817	CcSEcCtD
Galantamine—Diarrhoea—Etoposide—testicular cancer	0.000476	0.000814	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—testicular cancer	0.000475	0.000812	CcSEcCtD
Galantamine—Ill-defined disorder—Methotrexate—testicular cancer	0.000474	0.00081	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—testicular cancer	0.000474	0.00081	CcSEcCtD
Galantamine—Anaemia—Methotrexate—testicular cancer	0.000472	0.000807	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—testicular cancer	0.000472	0.000806	CcSEcCtD
Galantamine—Flushing—Doxorubicin—testicular cancer	0.000472	0.000806	CcSEcCtD
Galantamine—Flatulence—Epirubicin—testicular cancer	0.000471	0.000805	CcSEcCtD
Galantamine—Tension—Epirubicin—testicular cancer	0.000469	0.000802	CcSEcCtD
Galantamine—Dysgeusia—Epirubicin—testicular cancer	0.000468	0.0008	CcSEcCtD
Galantamine—Nervousness—Epirubicin—testicular cancer	0.000465	0.000794	CcSEcCtD
Galantamine—Back pain—Epirubicin—testicular cancer	0.000463	0.000791	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—testicular cancer	0.000461	0.000788	CcSEcCtD
Galantamine—Malaise—Methotrexate—testicular cancer	0.000461	0.000788	CcSEcCtD
Galantamine—Dizziness—Etoposide—testicular cancer	0.000461	0.000787	CcSEcCtD
Galantamine—Muscle spasms—Epirubicin—testicular cancer	0.00046	0.000786	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—testicular cancer	0.000459	0.000785	CcSEcCtD
Galantamine—Vertigo—Methotrexate—testicular cancer	0.000459	0.000785	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—testicular cancer	0.000454	0.000776	CcSEcCtD
Galantamine—Nausea—Cisplatin—testicular cancer	0.000452	0.000771	CcSEcCtD
Galantamine—Vision blurred—Epirubicin—testicular cancer	0.000451	0.00077	CcSEcCtD
Galantamine—Cough—Methotrexate—testicular cancer	0.000446	0.000762	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—testicular cancer	0.000445	0.000761	CcSEcCtD
Galantamine—Ill-defined disorder—Epirubicin—testicular cancer	0.000444	0.000758	CcSEcCtD
Galantamine—Convulsion—Methotrexate—testicular cancer	0.000443	0.000757	CcSEcCtD
Galantamine—Vomiting—Etoposide—testicular cancer	0.000443	0.000757	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—testicular cancer	0.000443	0.000756	CcSEcCtD
Galantamine—Anaemia—Epirubicin—testicular cancer	0.000442	0.000755	CcSEcCtD
Galantamine—Agitation—Epirubicin—testicular cancer	0.00044	0.000751	CcSEcCtD
Galantamine—Rash—Etoposide—testicular cancer	0.000439	0.00075	CcSEcCtD
Galantamine—Dermatitis—Etoposide—testicular cancer	0.000439	0.00075	CcSEcCtD
Galantamine—Headache—Etoposide—testicular cancer	0.000436	0.000745	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—testicular cancer	0.000436	0.000745	CcSEcCtD
Galantamine—Myalgia—Methotrexate—testicular cancer	0.000435	0.000743	CcSEcCtD
Galantamine—Arthralgia—Methotrexate—testicular cancer	0.000435	0.000743	CcSEcCtD
Galantamine—Chest pain—Methotrexate—testicular cancer	0.000435	0.000743	CcSEcCtD
Galantamine—Tension—Doxorubicin—testicular cancer	0.000434	0.000742	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—testicular cancer	0.000433	0.000741	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000432	0.000738	CcSEcCtD
Galantamine—Malaise—Epirubicin—testicular cancer	0.000431	0.000737	CcSEcCtD
Galantamine—Discomfort—Methotrexate—testicular cancer	0.00043	0.000735	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—testicular cancer	0.00043	0.000734	CcSEcCtD
Galantamine—Vertigo—Epirubicin—testicular cancer	0.00043	0.000734	CcSEcCtD
Galantamine—Syncope—Epirubicin—testicular cancer	0.000429	0.000733	CcSEcCtD
Galantamine—Back pain—Doxorubicin—testicular cancer	0.000428	0.000731	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—testicular cancer	0.000425	0.000727	CcSEcCtD
Galantamine—Palpitations—Epirubicin—testicular cancer	0.000423	0.000722	CcSEcCtD
Galantamine—Confusional state—Methotrexate—testicular cancer	0.000421	0.000719	CcSEcCtD
Galantamine—Loss of consciousness—Epirubicin—testicular cancer	0.00042	0.000718	CcSEcCtD
Galantamine—Cough—Epirubicin—testicular cancer	0.000417	0.000713	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—testicular cancer	0.000417	0.000713	CcSEcCtD
Galantamine—Convulsion—Epirubicin—testicular cancer	0.000414	0.000708	CcSEcCtD
Galantamine—Nausea—Etoposide—testicular cancer	0.000414	0.000707	CcSEcCtD
Galantamine—Hypertension—Epirubicin—testicular cancer	0.000413	0.000706	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000411	0.000702	CcSEcCtD
Galantamine—Nervous system disorder—Methotrexate—testicular cancer	0.000409	0.000699	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—testicular cancer	0.000409	0.000699	CcSEcCtD
Galantamine—Thrombocytopenia—Methotrexate—testicular cancer	0.000408	0.000698	CcSEcCtD
Galantamine—Chest pain—Epirubicin—testicular cancer	0.000407	0.000696	CcSEcCtD
Galantamine—Arthralgia—Epirubicin—testicular cancer	0.000407	0.000696	CcSEcCtD
Galantamine—Myalgia—Epirubicin—testicular cancer	0.000407	0.000696	CcSEcCtD
Galantamine—Agitation—Doxorubicin—testicular cancer	0.000407	0.000695	CcSEcCtD
Galantamine—Anxiety—Epirubicin—testicular cancer	0.000406	0.000693	CcSEcCtD
Galantamine—Skin disorder—Methotrexate—testicular cancer	0.000405	0.000692	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000404	0.000691	CcSEcCtD
Galantamine—Hyperhidrosis—Methotrexate—testicular cancer	0.000403	0.000689	CcSEcCtD
Galantamine—Discomfort—Epirubicin—testicular cancer	0.000402	0.000687	CcSEcCtD
Galantamine—Malaise—Doxorubicin—testicular cancer	0.000399	0.000682	CcSEcCtD
Galantamine—Dry mouth—Epirubicin—testicular cancer	0.000398	0.00068	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—testicular cancer	0.000398	0.000679	CcSEcCtD
Galantamine—Anorexia—Methotrexate—testicular cancer	0.000398	0.000679	CcSEcCtD
Galantamine—Syncope—Doxorubicin—testicular cancer	0.000397	0.000678	CcSEcCtD
Galantamine—Confusional state—Epirubicin—testicular cancer	0.000394	0.000673	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—testicular cancer	0.000391	0.000668	CcSEcCtD
Galantamine—Hypotension—Methotrexate—testicular cancer	0.00039	0.000666	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—testicular cancer	0.000389	0.000665	CcSEcCtD
Galantamine—Cough—Doxorubicin—testicular cancer	0.000386	0.00066	CcSEcCtD
Galantamine—Shock—Epirubicin—testicular cancer	0.000384	0.000656	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—testicular cancer	0.000383	0.000655	CcSEcCtD
Galantamine—Nervous system disorder—Epirubicin—testicular cancer	0.000383	0.000654	CcSEcCtD
Galantamine—Thrombocytopenia—Epirubicin—testicular cancer	0.000382	0.000653	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—testicular cancer	0.000382	0.000653	CcSEcCtD
Galantamine—Tachycardia—Epirubicin—testicular cancer	0.000381	0.000651	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00038	0.000649	CcSEcCtD
Galantamine—Skin disorder—Epirubicin—testicular cancer	0.000379	0.000648	CcSEcCtD
Galantamine—Hyperhidrosis—Epirubicin—testicular cancer	0.000377	0.000645	CcSEcCtD
Galantamine—Insomnia—Methotrexate—testicular cancer	0.000377	0.000645	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—testicular cancer	0.000377	0.000644	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—testicular cancer	0.000377	0.000644	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—testicular cancer	0.000377	0.000644	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—testicular cancer	0.000375	0.000642	CcSEcCtD
Galantamine—Paraesthesia—Methotrexate—testicular cancer	0.000375	0.00064	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000374	0.000639	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—testicular cancer	0.000372	0.000636	CcSEcCtD
Galantamine—Anorexia—Epirubicin—testicular cancer	0.000372	0.000636	CcSEcCtD
Galantamine—Somnolence—Methotrexate—testicular cancer	0.000371	0.000634	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—testicular cancer	0.000368	0.00063	CcSEcCtD
Galantamine—Dyspepsia—Methotrexate—testicular cancer	0.000367	0.000627	CcSEcCtD
Galantamine—Hypotension—Epirubicin—testicular cancer	0.000365	0.000623	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—testicular cancer	0.000364	0.000622	CcSEcCtD
Galantamine—Decreased appetite—Methotrexate—testicular cancer	0.000363	0.00062	CcSEcCtD
Galantamine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00036	0.000615	CcSEcCtD
Galantamine—Fatigue—Methotrexate—testicular cancer	0.00036	0.000614	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000356	0.000608	CcSEcCtD
Galantamine—Shock—Doxorubicin—testicular cancer	0.000355	0.000607	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—testicular cancer	0.000354	0.000605	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000354	0.000604	CcSEcCtD
Galantamine—Insomnia—Epirubicin—testicular cancer	0.000353	0.000603	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—testicular cancer	0.000353	0.000602	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—testicular cancer	0.000351	0.000599	CcSEcCtD
Galantamine—Paraesthesia—Epirubicin—testicular cancer	0.000351	0.000599	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000349	0.000597	CcSEcCtD
Galantamine—Somnolence—Epirubicin—testicular cancer	0.000347	0.000593	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—testicular cancer	0.000344	0.000588	CcSEcCtD
Galantamine—Feeling abnormal—Methotrexate—testicular cancer	0.000344	0.000587	CcSEcCtD
Galantamine—Dyspepsia—Epirubicin—testicular cancer	0.000344	0.000587	CcSEcCtD
Galantamine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000341	0.000583	CcSEcCtD
Galantamine—Decreased appetite—Epirubicin—testicular cancer	0.000339	0.00058	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—testicular cancer	0.000338	0.000577	CcSEcCtD
Galantamine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000337	0.000576	CcSEcCtD
Galantamine—Fatigue—Epirubicin—testicular cancer	0.000337	0.000575	CcSEcCtD
Galantamine—Constipation—Epirubicin—testicular cancer	0.000334	0.00057	CcSEcCtD
Galantamine—Abdominal pain—Methotrexate—testicular cancer	0.00033	0.000563	CcSEcCtD
Galantamine—Body temperature increased—Methotrexate—testicular cancer	0.00033	0.000563	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000329	0.000562	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—testicular cancer	0.000327	0.000558	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—testicular cancer	0.000324	0.000554	CcSEcCtD
Galantamine—Feeling abnormal—Epirubicin—testicular cancer	0.000322	0.00055	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—testicular cancer	0.000321	0.000549	CcSEcCtD
Galantamine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000319	0.000545	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—testicular cancer	0.000318	0.000543	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—testicular cancer	0.000314	0.000536	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000312	0.000533	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—testicular cancer	0.000311	0.000532	CcSEcCtD
Galantamine—Constipation—Doxorubicin—testicular cancer	0.000309	0.000528	CcSEcCtD
Galantamine—Abdominal pain—Epirubicin—testicular cancer	0.000309	0.000527	CcSEcCtD
Galantamine—Body temperature increased—Epirubicin—testicular cancer	0.000309	0.000527	CcSEcCtD
Galantamine—Hypersensitivity—Methotrexate—testicular cancer	0.000307	0.000525	CcSEcCtD
Galantamine—Asthenia—Methotrexate—testicular cancer	0.000299	0.000511	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—testicular cancer	0.000298	0.000509	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000295	0.000505	CcSEcCtD
Galantamine—Hypersensitivity—Epirubicin—testicular cancer	0.000288	0.000491	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—testicular cancer	0.000286	0.000488	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—testicular cancer	0.000286	0.000488	CcSEcCtD
Galantamine—Diarrhoea—Methotrexate—testicular cancer	0.000285	0.000488	CcSEcCtD
Galantamine—Asthenia—Epirubicin—testicular cancer	0.00028	0.000479	CcSEcCtD
Galantamine—Dizziness—Methotrexate—testicular cancer	0.000276	0.000471	CcSEcCtD
Galantamine—Diarrhoea—Epirubicin—testicular cancer	0.000267	0.000456	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—testicular cancer	0.000266	0.000455	CcSEcCtD
Galantamine—Vomiting—Methotrexate—testicular cancer	0.000265	0.000453	CcSEcCtD
Galantamine—Rash—Methotrexate—testicular cancer	0.000263	0.000449	CcSEcCtD
Galantamine—Dermatitis—Methotrexate—testicular cancer	0.000263	0.000449	CcSEcCtD
Galantamine—Headache—Methotrexate—testicular cancer	0.000261	0.000446	CcSEcCtD
Galantamine—Asthenia—Doxorubicin—testicular cancer	0.000259	0.000443	CcSEcCtD
Galantamine—Dizziness—Epirubicin—testicular cancer	0.000258	0.000441	CcSEcCtD
Galantamine—Vomiting—Epirubicin—testicular cancer	0.000248	0.000424	CcSEcCtD
Galantamine—Nausea—Methotrexate—testicular cancer	0.000248	0.000423	CcSEcCtD
Galantamine—Diarrhoea—Doxorubicin—testicular cancer	0.000247	0.000422	CcSEcCtD
Galantamine—Rash—Epirubicin—testicular cancer	0.000246	0.000421	CcSEcCtD
Galantamine—Dermatitis—Epirubicin—testicular cancer	0.000246	0.00042	CcSEcCtD
Galantamine—Headache—Epirubicin—testicular cancer	0.000245	0.000418	CcSEcCtD
Galantamine—Dizziness—Doxorubicin—testicular cancer	0.000239	0.000408	CcSEcCtD
Galantamine—Nausea—Epirubicin—testicular cancer	0.000232	0.000396	CcSEcCtD
Galantamine—Vomiting—Doxorubicin—testicular cancer	0.00023	0.000392	CcSEcCtD
Galantamine—Rash—Doxorubicin—testicular cancer	0.000228	0.000389	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—testicular cancer	0.000228	0.000389	CcSEcCtD
Galantamine—Headache—Doxorubicin—testicular cancer	0.000226	0.000387	CcSEcCtD
Galantamine—Nausea—Doxorubicin—testicular cancer	0.000215	0.000367	CcSEcCtD
